Traws Pharma, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
TRAW Company Description
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
TRAW Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view TRAW Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of TRAW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TRAW's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of TRAW in WallStreetBets Daily Discussion
TRAW News
Recent insights relating to TRAW
CNBC Recommendations
Recent picks made for TRAW stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in TRAW
Corporate Flights
Flights by private jets registered to TRAW
Our Analysis